Previous reports have shown that overexpression of L11 in ribosome-perturbed cells, but not in DNA-damaged or oncogene-activated cells, greatly increases L11-MDM2 binding in a p53-dependent manner both in normal and in tumor cells [19], [34]. Here, RPL11 is linked to neoplasm.